Crohn's Disease in
the Clinical Setting
About CIMZIA®
Dosing and
Administration
Clinical Trials Overview
Patient Support
Safety Information
Resources
For Patients & Caregivers
Prescribing Information


This site is intended for
US residents.

Crohn's Disease in the Clinical Setting

Many factors lead to the manifestation of Crohn's disease (CD) in individual patients. While the exact cause of CD is still unknown, much is understood about the pathophysiology of the disease. Today, factors like environment and genealogy are believed to contribute to the development of CD.

Learn more about CD:

 

 

 

 

 

 

 

CIMZIA is indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.
For more information 1.866.4.CIMZIA
CIMZIA